Re: A Phase 2 Trial of Sunitinib in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma

The Journal of Urology ◽

10.1016/j.juro.2012.08.167 ◽

2012 ◽

Vol 188 (6) ◽

pp. 2146-2147

Author(s):

Samir S. Taneja

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase 2 ◽

Cell Renal Cell Carcinoma ◽

Download Full-text

Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial

The Lancet Oncology ◽

10.1016/s1470-2045(15)00515-x ◽

2016 ◽

Vol 17 (3) ◽

pp. 378-388 ◽

Author(s):

Andrew J Armstrong ◽

Susan Halabi ◽

Tim Eisen ◽

Samuel Broderick ◽

Walter M Stadler ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase 2 ◽

Cell Renal Cell Carcinoma ◽

Download Full-text

Phase 2 Trial of Neoadjuvant Axitinib in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma

European Urology ◽

10.1016/j.eururo.2014.01.035 ◽

2014 ◽

Vol 66 (5) ◽

pp. 874-880 ◽

Author(s):

Jose A. Karam ◽

Catherine E. Devine ◽

Diana L. Urbauer ◽

Marisa Lozano ◽

Tapati Maity ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Locally Advanced ◽

Phase 2 ◽

Cell Renal Cell Carcinoma ◽

Download Full-text

Re: Phase 2 Trial of Neoadjuvant Axitinib in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma

European Urology ◽

10.1016/j.eururo.2015.03.012 ◽

2015 ◽

Vol 68 (2) ◽

pp. 336

Author(s):

Francesco Greco ◽

Vincenzo Mirone

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Locally Advanced ◽

Phase 2 ◽

Cell Renal Cell Carcinoma ◽

Download Full-text

Everolimus versus sunitinib prospective evaluation in metastatic non-clear cell renal cell carcinoma (The ESPN Trial): A multicenter randomized phase 2 trial.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.4505 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 4505-4505 ◽

Author(s):

Nizar M. Tannir ◽

Eric Jonasch ◽

Emre Altinmakas ◽

Chaan S. Ng ◽

Wei Qiao ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase 2 ◽

Prospective Evaluation ◽

Cell Renal Cell Carcinoma ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text

A phase 2 trial of lenvatinib in combination with everolimus in patients with advanced or metastatic non-clear cell renal cell carcinoma

European Urology Supplements ◽

10.1016/s1569-9056(17)30280-4 ◽

2017 ◽

Vol 16 (3) ◽

pp. e371

Author(s):

T. Hutson ◽

D. Xing ◽

C. Dutcus ◽

M. Baig ◽

M. Fishman

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase 2 ◽

Cell Renal Cell Carcinoma ◽

Download Full-text

Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial

European Urology ◽

10.1016/j.eururo.2015.10.049 ◽

2016 ◽

Vol 69 (5) ◽

pp. 866-874 ◽

Author(s):

Nizar M. Tannir ◽

Eric Jonasch ◽

Laurence Albiges ◽

Emre Altinmakas ◽

Chaan S. Ng ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase 2 ◽

Prospective Evaluation ◽

Cell Renal Cell Carcinoma ◽

Phase 2 Trial ◽

Multicenter Phase

Download Full-text

A Phase 2 Trial of Sunitinib in Patients with Advanced Non–clear Cell Renal Cell Carcinoma

European Urology ◽

10.1016/j.eururo.2012.06.043 ◽

2012 ◽

Vol 62 (6) ◽

pp. 1013-1019 ◽

Author(s):

Nizar M. Tannir ◽

Elizabeth Plimack ◽

Chaan Ng ◽

Pheroze Tamboli ◽

Nebiyou B. Bekele ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase 2 ◽

Cell Renal Cell Carcinoma ◽

Download Full-text

Re: Nizar M. Tannir, Eric Jonasch, Laurence Albiges, et al. Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN):A Randomized Multicenter Phase 2 Trial. Eur Urol 2016;69:866–74

European Urology ◽

10.1016/j.eururo.2016.06.016 ◽

2017 ◽

Vol 71 (1) ◽

pp. e23-e24

Author(s):

Zhenyu Yang ◽

Lin Qi ◽

Minfeng Chen

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase 2 ◽

Prospective Evaluation ◽

Cell Renal Cell Carcinoma ◽

Phase 2 Trial ◽

Multicenter Phase

Download Full-text

A phase 2 study of investigational TORC1/2 inhibitor TAK-228 and TAK-228 plus investigational PI3Kα-selective inhibitor TAK-117 vs everolimus in adults with advanced or metastatic clear-cell renal cell carcinoma (ccRCC) that has progressed on VEGF-targeted therapy

Annals of Oncology ◽

10.1093/annonc/mdx371.079 ◽

2017 ◽

Vol 28 ◽

pp. v328 ◽

Author(s):

T.K. Choueiri ◽

C. Porta ◽

C. Suarez Rodriguez ◽

R. Alter ◽

P. Czaykowski ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Selective Inhibitor ◽

Phase 2 ◽

Cell Renal Cell Carcinoma ◽

Download Full-text

Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study

European Urology Oncology ◽

10.1016/j.euo.2019.08.011 ◽

2019 ◽

Vol 2 (6) ◽

pp. 699-707

Author(s):

Giuseppe Procopio ◽

Giulia Apollonio ◽

Francesco Cognetti ◽

Rosalba Miceli ◽

Michele Milella ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase 2 ◽

Cell Renal Cell Carcinoma

Download Full-text